Evidence map›Paper›PMID 35531335›Full record

ArticleFrontiers in cellular and infection microbiology2022

Use of Bulk Segregant Analysis for Determining the Genetic Basis of Azole Resistance in the Opportunistic Pathogen

George D Ashton, Fei Sang, Martin Blythe, Daniel Zadik, Nadine Holmes, Sunir Malla, Simone M T Camps, Victoria Wright, Willem J G Melchers, Paul E Verweij and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Recent developments inMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Editorial: Sexual and Parasexual Reproduction of Human Fungal Pathogens.Frontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

George D AshtonSchool of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
Fei SangDeepSeq, Centre for Genetics and Genomics, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Martin BlytheDeepSeq, Centre for Genetics and Genomics, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Daniel ZadikDeepSeq, Centre for Genetics and Genomics, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Nadine HolmesDeepSeq, Centre for Genetics and Genomics, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Sunir MallaDeepSeq, Centre for Genetics and Genomics, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Simone M T CampsDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands.
Victoria WrightDeepSeq, Centre for Genetics and Genomics, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Willem J G MelchersDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands.
Paul E VerweijDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands.
Paul S DyerSchool of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
Queen's Medical Centre · GBRadboud University Nijmegen · NLUniversity of Nottingham · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

A sexual cycle was described in 2009 for the opportunistic fungal pathogen

Indexed as

Aspergillus fumigatusAzolesAntifungal AgentsDrug Resistance, FungalFungal ProteinsItraconazoleMicrobial Sensitivity TestsAntifungal AgentsAzolesFungal ProteinsItraconazoleantifungalCYP51filamentous fungigenomicsitraconazolenext-generation sequencing

Identifiers

PMID35531335
PMCPMC9069965
OpenAlexW4223422064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.